Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002102-37Phase 3Completed
Phase 3, randomised, open-label trial of clonidine and dexmedetomidine in rhinosinusitis and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Boezaart bleeding score. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002102-37.